tiprankstipranks
Trending News
More News >
Dermata Therapeutics (DRMA)
NASDAQ:DRMA
US Market

Dermata Therapeutics (DRMA) Technical Analysis

Compare
143 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
4Neutral
14Bearish
Technical Analysis Consensus
Buy
4Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Dermata Therapeutics’s (DRMA) Moving Averages Convergence Divergence (MACD) indicator is -0.07, suggesting Dermata Therapeutics is a Buy.
Dermata Therapeutics’s (DRMA) 20-Day exponential moving average is 2.27, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) 50-Day exponential moving average is 2.55, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.

Dermata Therapeutics (DRMA) Pivot Points

Feb 05, 2026, 11:22 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.44
1.62
1.73
1.91
2.02
2.20
2.31
Fibonacci
1.62
1.73
1.80
1.91
2.02
2.09
2.20
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Dermata Therapeutics (DRMA) Moving Averages

Feb 05, 2026, 11:22 AM
Period
Simple
Exponential
MA5
2.17Sell
2.09Sell
MA10
2.36Sell
2.21Sell
MA20
2.25Sell
2.27Sell
MA50
2.42Sell
2.55Sell
MA100
3.30Sell
3.38Sell
MA200
5.07Sell
5.33Sell
Dermata Therapeutics’s (DRMA) 10-Day exponential moving average is 2.21, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) 100-Day exponential moving average is 3.38, while Dermata Therapeutics’s (DRMA) share price is $2.14, making it a Sell.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 50-day simple moving average is 2.42, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 100-day simple moving average is 3.30, creating a Sell signal.
Dermata Therapeutics’s (DRMA) stock price is $2.14 and Dermata Therapeutics’s (DRMA) 200-day simple moving average is 5.07, creating a Sell signal.

Dermata Therapeutics (DRMA) Technical Indicators

Feb 05, 2026, 11:22 AM
Name
Value
Implied Action
RSI (14)
43.67
Neutral
STOCH (9,6)
2.45
Buy
STOCHRSI (14)
4.65
Buy
MACD (12,26)
-0.07
Buy
ADX (14)
27.90
Neutral
Williams %R
-95.45
Buy
CCI (14)
-94.68
Neutral
ATR (14)
0.44
-
Ultimate Oscillator
32.46
Neutral
ROC
-12.27
Sell
Dermata Therapeutics’s (DRMA) Relative Strength Index (RSI) is 43.67, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Trend Strength Indicator (ADX) is 27.90, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Commodity Channel Index (CCI) is -94.68, creating a Neutral signal.
Dermata Therapeutics’s (DRMA) Price Rate of Change (ROC) is -12.27, creating a Sell signal.

FAQ

Is DRMA a Buy, Hold, or Sell?
Based on DRMA’s technical indicators, DRMA is a Sell.
    What is DRMA’s RSI (14)?
    DRMA’s RSI (14) is 43.67, which suggests DRMA is a Neutral.
      What is DRMA’s MACD?
      DRMA’s MACD is -0.07, which suggests DRMA is a Buy.
        What is DRMA’s 5-day moving average?
        DRMA’s 5-day moving average is 2.17, which suggests DRMA is a Sell.
          What is DRMA’s 20-day moving average?
          DRMA 20-day moving average is 2.25, which suggests DRMA is a Sell.
            What is DRMA’s 50-day moving average?
            DRMA’s 50-day moving average is 2.42, which suggests DRMA is a Sell.
              What is DRMA’s 200-day moving average?
              DRMA’s 200-day moving average is 5.07, which suggests DRMA is a Sell.
                What is DRMA’s Williams % R (14)?
                DRMA’s Williams % R (14) is -95.45, which suggests DRMA is a Buy.
                  What is DRMA’s CCI (14)?
                  DRMA’s CCI (14) is -94.68, which suggests DRMA is a Neutral.